| 1301/1644 | US=2 / Mama Kim C, Song Y, Paik S. Assays for DNA abnormalities: assays for gene amplification. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 65-77. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; ANOMALIAS DO DNA; ENSAIOS PARA AMPLIFICACAO DO GENE; TRASTUZUMABE; TESTE HER-2 |
| 1302/1644 | US=2 / Mama Daidone MG, Silvestrini R, Amadori D. Tissue predictive biomakers: cell kinetics. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 81-109. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES DE TECIDO PREDITIVOS; CINETICA CELULAR; PADRONIZACAO DO ENSAIO; ENSAIOS CLINICOS; VARIACOES POS-TRATAMENTO |
| 1303/1644 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA |
| 1304/1644 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 129-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; VALOR PREDITIVO DE C-ERB-B2; HORMONIOTERAPIA; QUIMIOTERAPIA; CANCER DE MAMA; TRASTUZUMABE |
| 1305/1644 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 1306/1644 | US=2 / Mama Ciardiello F, Troiani T, Tortora G. Tissue predictive biomakers: the epidermal growth factor receptor pathway as a selective molecular-targeted treatment in human breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 177-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCAORES PREDITIVOS; FATOR DE CRESCIMENTO EPIDERMICO; VIA RECEPTOR; CANCER DE MAMA; EGF; EGFR |
| 1307/1644 | US=2 / Mama Kandioler D, Jakesk R. Tissue predictive biomakers: p53 as a prognostic and predicitive indicator. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 193-209. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |
| 1308/1644 | US=2 / Mama Braun S, Seeber J, Marth C. Predictive biomarkers in body fluids: occult metastatic cells in breast cancer patients. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 213-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CELULAS METASTATICAS; CANCER DE MAMA; PROGNOSTICO |
| 1309/1644 | US=2 / Mama Lipton A, Demmers L, Leitzel K, Ali SM, Neumann R, Price CP, Carney WP. Predictive biomarkers in body fluids: circulating HER2/neu: clinical utility. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 235-65. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO HER2/NEU; ONCOPROTEINA; CANCER DE MAMA |
| 1310/1644 | US=2 / Mama Sarmiento R, Franceschini R, Meo S, Gion M, Longo R, Gaspirini G. Predictive biomarkers in body fluids: circulating vascular endothelial growth factor. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 267-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; CANCER DE MAMA; ANGIOGENESE; TERAPIA; PROGNOSTICO |
| 1311/1644 | US=2 / Mama Hawes D, Cote RJ. Predictive biomarkers in body fluids: detection of early tumor dissemination in patients with breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 293-321. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; DETECCAO DE DISSEMINACAO DO TUMOR PRECOCE; CANCER DE MAMA; MEDULA OSSEA; CELULAS TUMORAIS CIRCULANTES; DISSEMINACAO DO TUMOR NO INICIO; CITOMETRIA DE FLUXO; IMUNO-HISTOQUIMICA; SEPARACAO IMUNO-MAGNETICA; LINFONODOS; MICROMETASTASES; METASTASES OCULTAS; SANGUE PERIFERICO; REACAO REVERSA DA CADEIA DE TRANSCRIPTASE-POLIMERASE; LINFONODO SENTINELA |
| 1312/1644 | US=2 / Mama Hawes D, Cote RJ. Future directions: new technologies/new markers/new challenges. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 325-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |
| 1313/1644 | US=2-A / Biol/Mol Bhojani MS, Laxman B, Ross BD, Rehemtulla A. Molecular diagnosis: molecular imaging in cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 703-27. ISBN 978-3-527-31237-5. DIAGNOSTICO MOLECULAR; IMAGIOLOGIA MOLECULAR; CANCER; IMAGEM OPTICO; IMAGEM DE BIOLUMINESCENCIA; IMAGEM FLUORESCENTE; RESSONANCIA MAGNETICA; IMAGEM NUCLEAR; IMAGEM MULTIMODAL; BIOMARCADORES; P53; METASTASE; ANGIOGENESE |
| 1314/1644 | US=25 / Odontologia Robinson WM, Borges-Osório MR. Conceitos básicos de genética molecular: DNA, RNA, funções, mutações. In: ___. Genética para odontologia. Porto Alegre: Artmed, 2006. p. 29-53. ISBN 85-3630716-1. GENETICA MOLECULAR; ACIDOS NUCLEICOS; CODIGO GENETICO; DNA; RNA; FUNCOES DO DNA; REGULACAO GENICA; MUTACAO |
| 1315/1644 | US=2-A / Biol/Mol Fulda S, Debatin KM. Molecular targets and therapeutics: therapeutic modulation of apoptosis in cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 847-61. ISBN 978-3-527-31237-5. METAS MOLECULARES; TERAPEUTICA MOLECULAR; MODULACAO TERAPEUTICA; APOPTOSE; CANCER. TERAPIA |
| 1316/1644 | US=2-A / Biol/Mol Fischer U, Schulze-Osthoff K. Molecular targets and therapeutics: current therapeutic strategies targeting caspases in disease. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 862-90. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; ESTRATEGIAS TERAPEUTICAS; CASPASES; CATALISADORES DE MORTE; RESPOSTAS IMUNE INATA; BIOQUIMICA DE CASPASES |
| 1317/1644 | US=2-A / Biol/Mol Stridh H, Bykov VJN, Selivanova G, Wiman KG. Molecular targets and therapeutics: cancer therapy by reactivation of the p53 apoptosis pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 891-912. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; CANCER. TERAPIA; REATIVACAO DA APOPTOSE; VIA P53; TERAPIA GENETICA |
| 1318/1644 | US=2-A / Biol/Mol Armstrong RC, Belli BA, Deckwerth TL. Molecular targets and therapeutics: small-molecular inhibitors of the of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 913-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DA PEQUENA MOLECULARES DE PROTEINAS; APOPTOSE |
| 1319/1644 | US=2-A / Biol/Mol Clarke PA, Powers M, Workman P. Molecular targets and therapeutics: inhibition of the molecular chaperone heat shock protein 90 in cancer: consequences for the regulation of survival signaling and induction of cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 933-65. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBICAO DA CHAPERONE; CHOQUE TERMICO 90; CANCER; REGULACAO DA SINALIZACAO; SOBREVIVENCIA; INDUCAO DE MORTE CELULAR; PROTEINA HSP90 |
| 1320/1644 | US=2-A / Biol/Mol Graville CA, Memmott RM, Gills JJ, Dennis PA. Molecular targets and therapeutics: targeting the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 966-96. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RAPAMICINA; FOSFOINOSITIDE-3-QUINASE; AKT; P13K/AKT |